GlassScriptPhysician profile
Elena L Mann
NPI 1750571105
$5,423.28
in general payments reported to CMS, 2019-2025
43 companies · $946 in 2025
The $946 reported for 2025 was more than what 90% of Obstetrics & Gynecology providers received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $811 · 2020: $725 · 2021: $808 · 2022: $610 · 2023: $719 · 2024: $805 · 2025: $946.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,470.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,469.98 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $1,009.67 | 2019-2025 | |
| Novo Nordisk INC | $764.99 | 2019-2025 | Ozempic, Rybelsus |
| Sumitomo Pharma America, INC. | $410.10 | 2023-2025 | Myfembree |
| Amgen INC. | $371.24 | 2019-2025 | Evenity, Prolia, Prolia |
| Corcept Therapeutics | $348.00 | 2019-2024 | Korlym |
| Astellas Pharma US INC | $250.76 | 2023-2025 | Veozah |
| Radius Health, INC. | $192.44 | 2019-2025 | Tymlos |
| Mayne Pharma Commercial LLC | $191.51 | 2021-2023 | |
| Lilly USA, LLC | $190.06 | 2020-2025 | Zepbound, Mounjaro |
| Evofem Biosciences, INC. | $163.65 | 2020-2025 | Phexxi, Solosec, Phexx |
| Hologic Sales and Service, LLC | $155.92 | 2020-2025 | Myosure Tissue Removal Device, Fluent Fluid Management System, Omni Hysteroscope |
| Avion Pharmaceuticals | $149.98 | 2019-2023 | Balcoltra |
| Millicent US INC | $116.62 | 2020-2025 | Intrarosa, Femring, Femlyv |
| Exeltis, USA INC. | $106.82 | 2019-2024 | Slynd |
| Organon LLC | $103.75 | 2021-2025 | Nexplanon, Jada System |
Show all 43 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Elena Mann listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.